Ruoß, M.; Damm, G.; Vosough, M.; Ehret, L.; Grom-Baumgarten, C.; Petkov, M.; Naddalin, S.; Ladurner, R.; Seehofer, D.; Nussler, A.;
et al. Epigenetic Modifications of the Liver Tumor Cell Line HepG2 Increase Their Drug Metabolic Capacity. Int. J. Mol. Sci. 2019, 20, 347.
https://doi.org/10.3390/ijms20020347
AMA Style
Ruoß M, Damm G, Vosough M, Ehret L, Grom-Baumgarten C, Petkov M, Naddalin S, Ladurner R, Seehofer D, Nussler A,
et al. Epigenetic Modifications of the Liver Tumor Cell Line HepG2 Increase Their Drug Metabolic Capacity. International Journal of Molecular Sciences. 2019; 20(2):347.
https://doi.org/10.3390/ijms20020347
Chicago/Turabian Style
Ruoß, Marc, Georg Damm, Massoud Vosough, Lisa Ehret, Carl Grom-Baumgarten, Martin Petkov, Silvio Naddalin, Ruth Ladurner, Daniel Seehofer, Andreas Nussler,
and et al. 2019. "Epigenetic Modifications of the Liver Tumor Cell Line HepG2 Increase Their Drug Metabolic Capacity" International Journal of Molecular Sciences 20, no. 2: 347.
https://doi.org/10.3390/ijms20020347
APA Style
Ruoß, M., Damm, G., Vosough, M., Ehret, L., Grom-Baumgarten, C., Petkov, M., Naddalin, S., Ladurner, R., Seehofer, D., Nussler, A., & Sajadian, S.
(2019). Epigenetic Modifications of the Liver Tumor Cell Line HepG2 Increase Their Drug Metabolic Capacity. International Journal of Molecular Sciences, 20(2), 347.
https://doi.org/10.3390/ijms20020347